Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 199INDUSTRY 110NIH 56NETWORK 34OTHER_GOV 3FED 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 2Retinoblastoma 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Topotecan × Clear all
NCT02980809 2016-12-02

Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer

First Hospitals affiliated to the China PLA General Hospital

Phase 2 Unknown
60 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02738346 2016-04-25

CBPC

University Hospital, Angers

Phase 3 Unknown
164 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00460876 2008-05-02

Phase I Trial of Periocular Topotecan in Retinoblastoma

Hospital JP Garrahan

Phase 1 Completed
5 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡